HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takahiro Hasebe Selected Research

Ductal Carcinoma

9/2013Histological factors for accurately predicting first locoregional recurrence of invasive ductal carcinoma of the breast.
4/2013Tumor-stromal interactions in breast tumor progression--significance of histological heterogeneity of tumor-stromal fibroblasts.
10/2011Important histologic outcome predictors for patients with invasive ductal carcinoma of the breast.
7/2011Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapy.
7/2010Metaplastic carcinoma of the breast.
5/2010Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.
5/2010p53 expression in tumor-stromal fibroblasts forming and not forming fibrotic foci in invasive ductal carcinoma of the breast.
4/2010Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy.
2/2010p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy.
11/2009p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breast.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takahiro Hasebe Research Topics

Disease

56Neoplasms (Cancer)
08/2022 - 01/2002
24Neoplasm Metastasis (Metastasis)
12/2013 - 03/2002
18Breast Neoplasms (Breast Cancer)
08/2022 - 07/2002
14Ductal Carcinoma
09/2013 - 02/2007
6Pancreatic Neoplasms (Pancreatic Cancer)
08/2010 - 03/2002
5Carcinoma (Carcinomatosis)
08/2018 - 08/2003
4Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 08/2004
3Lymphatic Metastasis
05/2019 - 01/2005
3Adenocarcinoma
12/2008 - 03/2002
3Prostatic Neoplasms (Prostate Cancer)
11/2006 - 05/2003
2Granuloma
09/2021 - 06/2021
2Hypoxia (Hypoxemia)
01/2018 - 01/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2008 - 08/2007
2Fibrosis (Cirrhosis)
05/2008 - 05/2005
2Necrosis
05/2008 - 11/2007
2Mesothelioma
09/2007 - 03/2005
2Lung Neoplasms (Lung Cancer)
06/2007 - 01/2004
2Colonic Neoplasms (Colon Cancer)
05/2007 - 01/2004
2Esophageal Neoplasms (Esophageal Cancer)
03/2006 - 01/2002
2Stomach Neoplasms (Stomach Cancer)
12/2005 - 01/2004
2Noninfiltrating Intraductal Carcinoma (DCIS)
06/2004 - 10/2002
1Granulomatous Mastitis
06/2021
1Inflammation (Inflammations)
06/2021
1Pain (Aches)
07/2020
1Ovarian Neoplasms (Ovarian Cancer)
03/2018
1Migraine with Aura (Familial Hemiplegic Migraine)
05/2017
1Aortic Coarctation
05/2017
1Migraine Disorders (Migraine)
05/2017
1Intracranial Hypertension
05/2017
1Hypotension (Low Blood Pressure)
05/2017
1Febrile Neutropenia
07/2015
1Myalgia
07/2015
1Vascular Tissue Neoplasms
06/2015
1Embolism (Embolus)
10/2011
1Lobular Carcinoma
07/2010
1Cholangiocarcinoma
03/2009
1Hepatocellular Carcinoma (Hepatoma)
03/2009
1Liver Neoplasms (Liver Cancer)
03/2009

Drug/Important Bio-Agent (IBA)

6Biological ProductsIBA
04/2013 - 06/2007
6Proteins (Proteins, Gene)FDA Link
08/2010 - 06/2004
6Insulin-Like PeptidesIBA
06/2007 - 01/2004
5Estrogen ReceptorsIBA
01/2018 - 05/2002
4Matrix Metalloproteinases (MMPs)IBA
12/2013 - 06/2005
3Messenger RNA (mRNA)IBA
05/2019 - 06/2005
3Progesterone Receptors (Progesterone Receptor)IBA
01/2018 - 05/2002
3ErbB Receptors (EGF Receptor)IBA
10/2017 - 01/2002
3Hormones (Hormone)IBA
06/2015 - 02/2007
3Hematoxylin (Haematoxylon)IBA
01/2011 - 01/2007
3Eosine Yellowish-(YS) (Eosin)IBA
01/2011 - 01/2007
3Biomarkers (Surrogate Marker)IBA
03/2009 - 01/2002
3Insulin-Like Growth Factor Binding Protein 3IBA
06/2007 - 01/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2005 - 01/2002
2Phenobarbital (Luminal)FDA Link
09/2021 - 10/2011
2fluoromisonidazoleIBA
01/2018 - 01/2018
2Dihydrolipoamide Dehydrogenase (Lipoamide Dehydrogenase)IBA
01/2011 - 04/2009
2Laminin (Merosin)IBA
08/2010 - 03/2002
2Capsules (Microcapsules)IBA
11/2007 - 01/2007
2Insulin-Like Growth Factor II (Somatomedin A)IBA
05/2007 - 09/2004
2Chromogranin AIBA
01/2007 - 08/2003
2SynaptophysinIBA
01/2007 - 08/2003
2Prostate-Specific Antigen (Semenogelase)IBA
11/2006 - 09/2004
2LigandsIBA
05/2006 - 09/2004
2Thymidylate SynthaseIBA
12/2005 - 01/2002
2Fluorouracil (Carac)FDA LinkGeneric
12/2005 - 01/2002
2Glutathione S-Transferase piIBA
12/2005 - 01/2002
2Cisplatin (Platino)FDA LinkGeneric
12/2005 - 01/2002
2Matrix Metalloproteinase 7 (Matrilysin)IBA
08/2005 - 01/2004
2Insulin-Like Growth Factor I (IGF-1)IBA
09/2004 - 01/2004
2beta CateninIBA
08/2004 - 05/2003
2Cyclin D1IBA
12/2003 - 01/2002
1Indicators and Reagents (Reagents)IBA
08/2022
1SiliconesIBA
09/2021
1Immunoglobulin M (IgM)IBA
06/2021
1Nucleic AcidsIBA
05/2019
1MucinsIBA
08/2018
1Histone Deacetylase InhibitorsIBA
03/2018
1Histone Deacetylases (Histone Deacetylase)IBA
03/2018
1Carboplatin (JM8)FDA LinkGeneric
10/2017
1Docetaxel (Taxotere)FDA Link
10/2017
1Trastuzumab (Herceptin)FDA Link
10/2017
112- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA
05/2017
1Coenzyme A (CoA)IBA
05/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2015
1Albumin-Bound PaclitaxelFDA Link
07/2015
1Epirubicin (Ellence)FDA LinkGeneric
07/2015
1CollagenIBA
04/2013
1Therapeutic UsesIBA
01/2011
1NAD (NADH)IBA
01/2011
1GlypicansIBA
03/2009

Therapy/Procedure

10Therapeutics
09/2013 - 07/2002
7Neoadjuvant Therapy
10/2017 - 10/2009
4Lymph Node Excision (Lymph Node Dissection)
05/2019 - 07/2002
3Drug Therapy (Chemotherapy)
03/2018 - 01/2005
2Segmental Mastectomy (Lumpectomy)
06/2021 - 04/2009
2Radiofrequency Ablation
01/2011 - 04/2009
2Chemoradiotherapy
03/2006 - 01/2002
1General Anesthesia
07/2020
1Deep Sedation
07/2020
1Stents
05/2017
1Adjuvant Radiotherapy
09/2013